XJZY: Injectable Vecuronium Bromide is expected to be selected for centralized procurement
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, XJZY announced that the company participated in the bidding work for the 11th batch of national centralized drug procurement organized by the National Organization for Drug Procurement Office from October 27 to October 28, 2025. The company's product, Vecuronium Bromide for Injection, is expected to be selected in this centralized procurement. The indications for this drug are: primarily as an adjunct to general anesthesia, used for tracheal intubation during general anesthesia and muscle relaxation during surgery
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments